Search

Find a vulnerability

Search criteria Use this form to refine search results.
Full-text search supports keyword queries with ranking and filtering.
You can combine vendor, product, and sources to narrow results.
Enable “Apply ordering” to sort by date instead of relevance.

    2 vulnerabilities by Apollo Pharmacy

    CVE-2026-50034 (GCVE-0-2026-50034)

    Vulnerability from cvelistv5 – Published: 2026-06-18 23:47 – Updated: 2026-06-22 14:54
    VLAI
    Title
    Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
    Summary
    An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
    SSVC
    Exploitation: none Automatable: no Technical Impact: partial
    CISA Coordinator (v2.0.3)
    CWE
    Assigner
    Impacted products
    Credits
    Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.
    Show details on NVD website

    {
      "containers": {
        "adp": [
          {
            "metrics": [
              {
                "other": {
                  "content": {
                    "id": "CVE-2026-50034",
                    "options": [
                      {
                        "Exploitation": "none"
                      },
                      {
                        "Automatable": "no"
                      },
                      {
                        "Technical Impact": "partial"
                      }
                    ],
                    "role": "CISA Coordinator",
                    "timestamp": "2026-06-22T14:54:09.331370Z",
                    "version": "2.0.3"
                  },
                  "type": "ssvc"
                }
              }
            ],
            "providerMetadata": {
              "dateUpdated": "2026-06-22T14:54:21.615Z",
              "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
              "shortName": "CISA-ADP"
            },
            "title": "CISA ADP Vulnrichment"
          }
        ],
        "cna": {
          "affected": [
            {
              "defaultStatus": "unaffected",
              "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)",
              "vendor": "Apollo Pharmacy",
              "versions": [
                {
                  "status": "affected",
                  "version": "0x0110_v1.1.0"
                }
              ]
            }
          ],
          "credits": [
            {
              "lang": "en",
              "type": "finder",
              "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA."
            }
          ],
          "descriptions": [
            {
              "lang": "en",
              "supportingMedia": [
                {
                  "base64": false,
                  "type": "text/html",
                  "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."
                }
              ],
              "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."
            }
          ],
          "metrics": [
            {
              "cvssV3_1": {
                "attackComplexity": "LOW",
                "attackVector": "ADJACENT_NETWORK",
                "availabilityImpact": "NONE",
                "baseScore": 6.5,
                "baseSeverity": "MEDIUM",
                "confidentialityImpact": "HIGH",
                "integrityImpact": "NONE",
                "privilegesRequired": "NONE",
                "scope": "UNCHANGED",
                "userInteraction": "NONE",
                "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N",
                "version": "3.1"
              },
              "format": "CVSS",
              "scenarios": [
                {
                  "lang": "en",
                  "value": "GENERAL"
                }
              ]
            },
            {
              "cvssV4_0": {
                "Automatable": "NOT_DEFINED",
                "Recovery": "NOT_DEFINED",
                "Safety": "NOT_DEFINED",
                "attackComplexity": "LOW",
                "attackRequirements": "NONE",
                "attackVector": "ADJACENT",
                "baseScore": 7.1,
                "baseSeverity": "HIGH",
                "exploitMaturity": "NOT_DEFINED",
                "privilegesRequired": "NONE",
                "providerUrgency": "NOT_DEFINED",
                "subAvailabilityImpact": "NONE",
                "subConfidentialityImpact": "NONE",
                "subIntegrityImpact": "NONE",
                "userInteraction": "NONE",
                "valueDensity": "NOT_DEFINED",
                "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N",
                "version": "4.0",
                "vulnAvailabilityImpact": "NONE",
                "vulnConfidentialityImpact": "HIGH",
                "vulnIntegrityImpact": "NONE",
                "vulnerabilityResponseEffort": "NOT_DEFINED"
              },
              "format": "CVSS",
              "scenarios": [
                {
                  "lang": "en",
                  "value": "GENERAL"
                }
              ]
            }
          ],
          "problemTypes": [
            {
              "descriptions": [
                {
                  "cweId": "CWE-319",
                  "description": "CWE-319",
                  "lang": "en",
                  "type": "CWE"
                }
              ]
            }
          ],
          "providerMetadata": {
            "dateUpdated": "2026-06-18T23:47:13.970Z",
            "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
            "shortName": "icscert"
          },
          "references": [
            {
              "url": "https://www.apollopharmacy.in/contact-us"
            },
            {
              "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
            },
            {
              "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
            },
            {
              "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
            }
          ],
          "source": {
            "advisory": "ICSMA-26-169-01",
            "discovery": "EXTERNAL"
          },
          "title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information",
          "workarounds": [
            {
              "lang": "en",
              "supportingMedia": [
                {
                  "base64": false,
                  "type": "text/html",
                  "value": "\u003cp\u003eApollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\u003cbr\u003e\u003ca href=\"https://www.apollopharmacy.in/contact-us\"\u003ehttps://www.apollopharmacy.in/contact-us\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003eCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u0026nbsp;\u003cbr\u003e\u003ca href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\"\u003ehttps://www.cisa.gov/news-events/news/understanding-bluetooth-technology\u003c/a\u003e\u003c/p\u003e"
                }
              ],
              "value": "Apollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
            }
          ],
          "x_generator": {
            "engine": "Vulnogram 1.0.2"
          }
        }
      },
      "cveMetadata": {
        "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "assignerShortName": "icscert",
        "cveId": "CVE-2026-50034",
        "datePublished": "2026-06-18T23:47:13.970Z",
        "dateReserved": "2026-06-10T21:21:12.237Z",
        "dateUpdated": "2026-06-22T14:54:21.615Z",
        "state": "PUBLISHED"
      },
      "dataType": "CVE_RECORD",
      "dataVersion": "5.2"
    }

    CVE-2026-52866 (GCVE-0-2026-52866)

    Vulnerability from cvelistv5 – Published: 2026-06-18 23:45 – Updated: 2026-06-22 14:52
    VLAI
    Title
    Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
    Summary
    An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
    SSVC
    Exploitation: none Automatable: no Technical Impact: partial
    CISA Coordinator (v2.0.3)
    CWE
    Assigner
    Impacted products
    Credits
    Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.
    Show details on NVD website

    {
      "containers": {
        "adp": [
          {
            "metrics": [
              {
                "other": {
                  "content": {
                    "id": "CVE-2026-52866",
                    "options": [
                      {
                        "Exploitation": "none"
                      },
                      {
                        "Automatable": "no"
                      },
                      {
                        "Technical Impact": "partial"
                      }
                    ],
                    "role": "CISA Coordinator",
                    "timestamp": "2026-06-22T14:51:51.052831Z",
                    "version": "2.0.3"
                  },
                  "type": "ssvc"
                }
              }
            ],
            "providerMetadata": {
              "dateUpdated": "2026-06-22T14:52:06.602Z",
              "orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
              "shortName": "CISA-ADP"
            },
            "title": "CISA ADP Vulnrichment"
          }
        ],
        "cna": {
          "affected": [
            {
              "defaultStatus": "unaffected",
              "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)",
              "vendor": "Apollo Pharmacy",
              "versions": [
                {
                  "status": "affected",
                  "version": "0x0110_v1.1.0"
                }
              ]
            }
          ],
          "credits": [
            {
              "lang": "en",
              "type": "finder",
              "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA."
            }
          ],
          "descriptions": [
            {
              "lang": "en",
              "supportingMedia": [
                {
                  "base64": false,
                  "type": "text/html",
                  "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
                }
              ],
              "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
            }
          ],
          "metrics": [
            {
              "cvssV3_1": {
                "attackComplexity": "LOW",
                "attackVector": "ADJACENT_NETWORK",
                "availabilityImpact": "HIGH",
                "baseScore": 6.5,
                "baseSeverity": "MEDIUM",
                "confidentialityImpact": "NONE",
                "integrityImpact": "NONE",
                "privilegesRequired": "NONE",
                "scope": "UNCHANGED",
                "userInteraction": "NONE",
                "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H",
                "version": "3.1"
              },
              "format": "CVSS",
              "scenarios": [
                {
                  "lang": "en",
                  "value": "GENERAL"
                }
              ]
            },
            {
              "cvssV4_0": {
                "Automatable": "NOT_DEFINED",
                "Recovery": "NOT_DEFINED",
                "Safety": "NOT_DEFINED",
                "attackComplexity": "LOW",
                "attackRequirements": "NONE",
                "attackVector": "ADJACENT",
                "baseScore": 7.1,
                "baseSeverity": "HIGH",
                "exploitMaturity": "NOT_DEFINED",
                "privilegesRequired": "NONE",
                "providerUrgency": "NOT_DEFINED",
                "subAvailabilityImpact": "NONE",
                "subConfidentialityImpact": "NONE",
                "subIntegrityImpact": "NONE",
                "userInteraction": "NONE",
                "valueDensity": "NOT_DEFINED",
                "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N",
                "version": "4.0",
                "vulnAvailabilityImpact": "HIGH",
                "vulnConfidentialityImpact": "NONE",
                "vulnIntegrityImpact": "NONE",
                "vulnerabilityResponseEffort": "NOT_DEFINED"
              },
              "format": "CVSS",
              "scenarios": [
                {
                  "lang": "en",
                  "value": "GENERAL"
                }
              ]
            }
          ],
          "problemTypes": [
            {
              "descriptions": [
                {
                  "cweId": "CWE-862",
                  "description": "CWE-862",
                  "lang": "en",
                  "type": "CWE"
                }
              ]
            }
          ],
          "providerMetadata": {
            "dateUpdated": "2026-06-18T23:45:34.263Z",
            "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
            "shortName": "icscert"
          },
          "references": [
            {
              "url": "https://www.apollopharmacy.in/contact-us"
            },
            {
              "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
            },
            {
              "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
            },
            {
              "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
            }
          ],
          "source": {
            "advisory": "ICSMA-26-169-01",
            "discovery": "EXTERNAL"
          },
          "title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization",
          "workarounds": [
            {
              "lang": "en",
              "supportingMedia": [
                {
                  "base64": false,
                  "type": "text/html",
                  "value": "\u003cp\u003eApollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\u003cbr\u003e\u003ca href=\"https://www.apollopharmacy.in/contact-us\"\u003ehttps://www.apollopharmacy.in/contact-us\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003eCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u0026nbsp;\u003cbr\u003e\u003ca href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\"\u003ehttps://www.cisa.gov/news-events/news/understanding-bluetooth-technology\u003c/a\u003e\u003c/p\u003e"
                }
              ],
              "value": "Apollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
            }
          ],
          "x_generator": {
            "engine": "Vulnogram 1.0.2"
          }
        }
      },
      "cveMetadata": {
        "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "assignerShortName": "icscert",
        "cveId": "CVE-2026-52866",
        "datePublished": "2026-06-18T23:45:34.263Z",
        "dateReserved": "2026-06-10T21:21:12.261Z",
        "dateUpdated": "2026-06-22T14:52:06.602Z",
        "state": "PUBLISHED"
      },
      "dataType": "CVE_RECORD",
      "dataVersion": "5.2"
    }